Meeting
2019 ASCO Annual Meeting
Circulating tumor DNA analysis (ctDNA) for genomic testing in NSCLC patients with isolated CNS progression.
Authors
Mihaela Aldea
Medical Oncology Department, Gustave Roussy, Villejuif, France
Mihaela Aldea , Laura Mezquita , Lizza Hendriks , Edouard Auclin , Jordi Remon , David Planchard , Cecile Jovelet , Jose Carlos Benitez , Anas Gazzah , Pernelle Lavaud , Charles Naltet , Ludovic Lacroix , Clive D. Morris , Emma Green , Karen Howarth , Claudio Nicotra , Benjamin Besse
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Brain Metastases
Citation
J Clin Oncol 37, 2019 (suppl; abstr 2015)
DOI
10.1200/JCO.2019.37.15_suppl.2015
Abstract #
2015
Poster Bd #
204
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Molecular characterization of NF1-mutated NSCLC and clinical outcomes.
First Author: Christopher Gates
Poster
2023 ASCO Annual Meeting
First results from the RETgistry: A global consortium for the study of resistance to RET inhibition in RET-altered solid tumors.
First Author: Alissa Jamie Cooper
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Circulating tumor DNA–based genomic landscape of KRAS wild-type pancreatic adenocarcinoma.
First Author: Brendon Fusco
Poster
2020 ASCO Virtual Scientific Program
MSK-ACCESS for noninvasive somatic mutation profiling of lung cancers utilizing circulating tumor DNA.
First Author: Emily S. Lebow